{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:33:05Z","timestamp":1781148785467,"version":"3.54.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:p>\n                    Adenomyosis is an estrogen-dependent uterine disorder increasingly recognized as a major cause of infertility and adverse obstetric outcomes, yet optimal medical preparation before embryo transfer (ET) remains uncertain. Adenomyotic lesions create a hyperestrogenic, inflammatory, and architecturally distorted uterine environment that may impair endometrial receptivity and increase miscarriage risk, compromising assisted reproductive technology (ART) success. This review summarizes current evidence on extended hormonal suppression in patients with adenomyosis undergoing\n                    <jats:italic>in vitro<\/jats:italic>\n                    fertilization and ET. We examine the rationale, protocols, and reproductive outcomes of ultra-long gonadotropin-releasing hormone agonist (GnRHa) regimens, intensified suppression with GnRHa plus aromatase inhibitors, levonorgestrel-releasing intrauterine systems, oral dienogest, and continuous combined oral contraceptives. Available data suggest that prolonged GnRHa pretreatment, particularly in freeze-all strategies with frozen ET, may improve implantation and reduce miscarriage, with additional benefit from deeper suppression in selected severe cases. Progestin-based approaches appear promising but remain less well studied, while combined oral contraceptives mainly provide symptom control. The review highlights the heterogeneity and methodological limitations of existing studies and underscores the need for well-designed trials to define the optimal regimen, duration, and patient selection criteria for extended hormonal suppression before ET in women with adenomyosis.\n                  <\/jats:p>","DOI":"10.3389\/frph.2026.1760832","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:45:28Z","timestamp":1770273928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of extended hormonal suppression in patients with adenomyosis undergoing embryo transfer"],"prefix":"10.3389","volume":"8","author":[{"given":"Andrea","family":"Etrusco","sequence":"first","affiliation":[{"name":"AMBRA fertility center","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Maiorana","sequence":"additional","affiliation":[{"name":"Gynaecologic and Obstetric Unit, ARNAS Civico Di Cristina Fatebenefratelli","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Roncarati","sequence":"additional","affiliation":[{"name":"Division of Gynaecology and Human Reproduction Physiopathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna","place":["Bologna, Italy"]},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Cozzolino","sequence":"additional","affiliation":[{"name":"IVIRMA Global Research Alliance, IVI Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/humupd\/dmab017","article-title":"Adenomyosis pathogenesis: insights from next-generation sequencing","volume":"27","author":"Bulun","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2017.12.030","article-title":"Pathogenesis of uterine adenomyosis: invagination or metaplasia?","volume":"109","author":"Garc\u00eda-Solares","year":"2018","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1571727","DOI":"10.3389\/fendo.2025.1571727","article-title":"Efficacy and safety of hormone therapies for treating adenomyosis-associated pelvic pain: a systematic review and network meta-analysis of randomized controlled trials","volume":"16","author":"Etrusco","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"104444","DOI":"10.1016\/j.rbmo.2024.104444","article-title":"The first lugano workshop on the role of adenomyosis in ART","volume":"50","author":"Cozzolino","year":"2025","journal-title":"Reprod Biomed Online"},{"key":"B5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jama.2020.26436","article-title":"Diagnosis, evaluation, and treatment of adenomyosis","volume":"326","author":"Kho","year":"2021","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1007\/s43032-021-00818-6","article-title":"The effect of uterine adenomyosis on IVF outcomes: a systematic review and meta-analysis","volume":"29","author":"Cozzolino","year":"2022","journal-title":"Reprod Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/humrep\/dep474","article-title":"The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders?","volume":"25","author":"Brosens","year":"2010","journal-title":"Hum Reprod"},{"key":"B8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.fertnstert.2023.11.034","article-title":"Impact of adenomyosis on in vitro fertilization outcomes in women undergoing donor oocyte transfers: a prospective observational study","volume":"121","author":"Cozzolino","year":"2024","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2025.11.008","article-title":"The ADELIN analysis: the presence of ADenomyosis and its effects on matErnal, neonataL, and obstetrIc outcomes: a systematic review and meta-aNalysis","author":"Etrusco","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fendo.2020.00318","article-title":"Impact of gonadotropin-releasing hormone agonist Pre-treatment on the cumulative live birth rate in infertile women with adenomyosis treated with IVF\/ICSI: a retrospective cohort study","volume":"11","author":"Chen","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1038\/s41598-023-34045-7","article-title":"Impact of adenomyosis and endometriosis on IVF\/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.rbmo.2022.09.023","article-title":"Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis","volume":"46","author":"Cozzolino","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"B13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/1471-0528.18026","article-title":"Effect of gonadotropin-releasing hormone agonist Pre-treatment on outcomes of fresh and frozen embryo transfers in women with adenomyosis: a retrospective cohort study with literature review","volume":"132","author":"Li","year":"2025","journal-title":"BJOG"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s40265-023-01957-7","article-title":"Current medical therapy for adenomyosis: from bench to bedside","volume":"83","author":"Etrusco","year":"2023","journal-title":"Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5653\/cerm.2016.43.3.169","article-title":"Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment","volume":"43","author":"Park","year":"2016","journal-title":"Clin Exp Reprod Med"},{"key":"B16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.rbmo.2022.09.021","article-title":"The effect of adenomyosis types on clinical outcomes of IVF embryo transfer after ultra-long GnRH agonist protocol","volume":"46","author":"Han","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"B17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4103\/gmit.gmit_53_24","article-title":"The art of managing infertile patients with adenomyosis","volume":"13","author":"Pai","year":"2024","journal-title":"Gynecol Minim Invasive Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/GMIT.GMIT_35_18","article-title":"Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis","volume":"7","author":"Matsushima","year":"2018","journal-title":"Gynecol Minim Invasive Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/humrep\/dep437","article-title":"Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy","volume":"25","author":"Khan","year":"2010","journal-title":"Hum Reprod"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.fertnstert.2010.09.060","article-title":"HOXA10 Expression is decreased in endometrium of women with adenomyosis","volume":"95","author":"Fischer","year":"2011","journal-title":"Fertil Steril"},{"key":"B21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.fertnstert.2017.06.025","article-title":"Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis","volume":"108","author":"Younes","year":"2017","journal-title":"Fertil Steril"},{"key":"B22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.rbmo.2021.10.014","article-title":"Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis","volume":"44","author":"Wu","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"B23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.fertnstert.2023.11.039","article-title":"The \u201cfreeze-all\u201d strategy seems to improve the chances of birth in adenomyosis-affected women","volume":"121","author":"Bourdon","year":"2024","journal-title":"Fertil Steril"},{"key":"B24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/1933719112438061","article-title":"The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis","volume":"19","author":"Chwalisz","year":"2012","journal-title":"Reprod Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s0015-0282(02)04813-6","article-title":"Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas","volume":"79","author":"Ishihara","year":"2003","journal-title":"Fertil Steril"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1468.e9","DOI":"10.1016\/j.fertnstert.2006.09.010","article-title":"Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist","volume":"87","author":"Kimura","year":"2007","journal-title":"Fertil Steril"},{"key":"B27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.fertnstert.2019.03.021","article-title":"Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure","volume":"112","author":"Steiner","year":"2019","journal-title":"Fertil Steril"},{"key":"B28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1600-0412.2012.01350.x","article-title":"Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial","volume":"91","author":"Badawy","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.rbmo.2019.03.101","article-title":"Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis","volume":"39","author":"Liang","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"B30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/aogs.13798","article-title":"The role of levonorgestrel intra-uterine system in the management of adenomyosis: a systematic review and meta-analysis of prospective studies","volume":"99","author":"Abbas","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B31","doi-asserted-by":"publisher","first-page":"373.e1","DOI":"10.1016\/j.ajog.2007.10.798","article-title":"Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis","volume":"198","author":"Cho","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1517\/14656566.2014.953055","article-title":"An update on the pharmacological management of adenomyosis","volume":"15","author":"Streuli","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"B33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1590\/S0100-72032006000800006","article-title":"Aplica\u00e7\u00e3o de dispositivo intra-uterino liberador de levonorgestrel, previamente a ciclos de fertiliza\u00e7\u00e3o in vitro, nas portadoras de adenomiose","volume":"28","author":"Donadio","year":"2006","journal-title":"Rev Bras Ginecol Obstet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12958-025-01349-4","article-title":"The role of different LNG-IUS therapies in the management of adenomyosis: a systematic review and meta-analysis","volume":"23","author":"Zhang","year":"2025","journal-title":"Reprod Biol Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00404-023-07271-7","article-title":"Evaluation of long-term efficacy and safety of dienogest in patients with chronic cyclic pelvic pain associated with endometriosis","volume":"309","author":"Maiorana","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/diagnostics15010030","article-title":"Effect of treatment with progestins and antiplatelet agents on IVF in women with adenomyosis and recurrent implantation failure","volume":"15","author":"Pacu","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bpobgyn.2016.09.006","article-title":"Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management","volume":"40","author":"Abbott","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.tjog.2024.01.001","article-title":"Heavy uterine bleeding in women with endometriosis and adenomyosis treated with dienogest","volume":"63","author":"Chou","year":"2024","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00404-015-3755-5","article-title":"Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial","volume":"292","author":"Fawzy","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejogrb.2014.05.031","article-title":"Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells","volume":"179","author":"Yamanaka","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.tjog.2021.09.037","article-title":"Segmented in vitro fertilization and frozen embryo transfer in dienogest-treated patient with adenomyosis: a case report and lierature review","volume":"61","author":"Feng","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.18565\/aig.2021.7.113-120","article-title":"Pretreatment before in vitro fertilization and its effectiveness in patients with diffuse adenomyosis","author":"Aksenenko","year":"2021","journal-title":"Obstet Gynecol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.3390\/jcm12196130","article-title":"The present and the future of medical therapies for adenomyosis","volume":"12","author":"Moawad","year":"2023","journal-title":"A Narrative Review. J Clin Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/17512433.2020.1721280","article-title":"Pharmacodynamics of combined estrogen-progestin oral contraceptives: 4. Effects on uterine and cervical epithelia","volume":"13","author":"Bastianelli","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ijgo.13600","article-title":"Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: a randomized clinical trial","volume":"154","author":"Hassanin","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"B46","article-title":"Ovarian Stimulation for IVF\/ICSI","year":""},{"key":"B47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.contraception.2015.05.015","article-title":"Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial","volume":"92","author":"Shaaban","year":"2015","journal-title":"Contraception"},{"key":"B48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/uog.24786","article-title":"Consensus on revised definitions of morphological uterus sonographic assessment (MUSA) features of adenomyosis: results of modified delphi procedure","volume":"60","author":"Harmsen","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1246819","DOI":"10.3389\/fendo.2023.1246819","article-title":"The role of the junctional zone in the management of adenomyosis with infertility","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B50","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3109\/09513590.2013.824960","article-title":"Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis","volume":"29","author":"Niu","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.rbmo.2020.07.027","article-title":"The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment","volume":"41","author":"Hou","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"B52","doi-asserted-by":"publisher","first-page":"481","DOI":"10.18502\/ijrm.v21i6.13635","article-title":"Pregnancy outcomes in women with adenomyosis, undergoing artificial endometrial preparation with and without gonadotropin-releasing hormone agonist pretreatment in frozen embryo transfer cycles: an RCT","volume":"21","author":"Eslami Moayed","year":"2023","journal-title":"Int J Reprod Biomed"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1133042","DOI":"10.3389\/fmed.2023.1133042","article-title":"Individualized conservative therapeutic strategies for adenomyosis with the aim of preserving fertility","volume":"10","author":"Han","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"CD005072","DOI":"10.1002\/14651858.CD005072.pub4","article-title":"Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery","volume":"12","author":"Gibbons","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"609771","DOI":"10.3389\/fendo.2021.609771","article-title":"Ultra-Long GnRH agonist protocol during IVF\/ICSI improves pregnancy outcomes in women with adenomyosis: a retrospective cohort study","volume":"12","author":"Lan","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"786132","DOI":"10.1155\/2012\/786132","article-title":"Infertility and adenomyosis","volume":"2012","author":"Campo","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"B57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/GCO.0b013e3282f1bf00","article-title":"Transvaginal ultrasound or MRI for diagnosis of adenomyosis","volume":"19","author":"Dueholm","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"104837","DOI":"10.1016\/j.rbmo.2025.104837","article-title":"Adenomyosis: the missed disease","volume":"50","author":"Santulli","year":"2025","journal-title":"Reprod Biomed Online"},{"key":"B59","doi-asserted-by":"publisher","first-page":"102228","DOI":"10.1016\/j.jogoh.2021.102228","article-title":"Adenomyosis: an update regarding its diagnosis and clinical features","volume":"50","author":"Bourdon","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2026.1760832\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:45:29Z","timestamp":1770273929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2026.1760832\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":59,"alternative-id":["10.3389\/frph.2026.1760832"],"URL":"https:\/\/doi.org\/10.3389\/frph.2026.1760832","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"article-number":"1760832"}}